These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3608625)

  • 1. In vitro susceptibility of Mycobacterium avium to a new macrolide (RU-28965).
    Casal M; Rodriguez F; Villalba R
    Chemotherapy; 1987; 33(4):255-8. PubMed ID: 3608625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965.
    Casal M; Gutierrez J; Gonzalez J; Ruiz P
    Tubercle; 1987 Jun; 68(2):141-3. PubMed ID: 3116734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M; Gutierrez J; González J; Ruiz P
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory M
    Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Mycobacterium avium complex to antibacterial agents.
    Davis CE; Carpenter JL; Trevino S; Koch J; Ognibene AJ
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):149-55. PubMed ID: 3440370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A; Soltani F
    Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A; Soltani F; Moshafi MH
    Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro bacteriostatic and bactericidal activity of isoniazid on the Mycobacterium avium-Mycobacterium intracellulare complex.
    Tsukamura M
    Tubercle; 1990 Sep; 71(3):199-204. PubMed ID: 2238126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M
    Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
    Nash DR; Steingrube VA
    Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
    Rastogi N; Labrousse V
    Antimicrob Agents Chemother; 1991 Mar; 35(3):462-70. PubMed ID: 1828135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in isoniazid susceptibility of Mycobacterium avium during the cell cycle.
    McCarthy CM
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):450-3. PubMed ID: 7224357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects.
    Heifets LB; Iseman MD; Lindholm-Levy PJ
    Am Rev Respir Dis; 1988 Mar; 137(3):711-5. PubMed ID: 2830814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.